China Resources Pharmaceutical Group Limited
Research China Resources Pharmaceutical Group Limited (3320.HK) on Bullrun: market cap HKD 28.93B, P/E 6.2, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3320.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 28.93B
- P/E6.2
- Dividend yield5.2%
- Financial periodFY2025
- RevenueCNY 269.57B
- Revenue growth4.6%
- Net incomeCNY 4.05B
- Free cash flowCNY 16.93B
- Gross margin16.5%
Valuation Snapshot
latest market cap is HKD 28.93B; P/E is 6.2; dividend yield is 5.2%.
Peer valuation comparison
Latest P/E is 6.22x versus a Healthcare sector median of 21.69x (71.3% below).
Latest dividend yield is 5.15% versus a Healthcare sector median of 2.41% (113.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 269.57B | CNY 4.05B | CNY 16.93B | 16.5% | 0.64 | CNY 15.84B | CNY 72.41B | CNY 51.41B |
| FY2024 | CNY 257.67B | CNY 3.35B | CNY 14.33B | 15.8% | 0.53 | CNY 16.42B | CNY 69.01B | CNY 48.24B |
| FY2023 | CNY 244.70B | CNY 3.85B | CNY 12.42B | 15.7% | 0.61 | CNY 24.65B | CNY 62.16B | CNY 45.96B |
| FY2022 | CNY 218.18B | CNY 3.50B | CNY 8.08B | 15.4% | 0.56 | CNY 15.22B | CNY 46.61B | CNY 43.56B |
| FY2021 | n/a | n/a | n/a | n/a | 0.49 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 28.93B | 6.2 | 5.2% | 0.24 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.24 HKD, yield 5.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.13 CNY |
| FY2024 | 0.26 CNY |
| FY2023 | 0.16 CNY |
| FY2022 | 0.15 CNY |
| FY2021 | 0.12 CNY |
About China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Resources Pharmaceutical Group Limited's market cap?
China Resources Pharmaceutical Group Limited's market capitalization is HKD 28.93B.
What is China Resources Pharmaceutical Group Limited's P/E ratio?
China Resources Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 6.2.
Does China Resources Pharmaceutical Group Limited pay a dividend?
China Resources Pharmaceutical Group Limited has a dividend yield of 5.2%.
What does China Resources Pharmaceutical Group Limited do?
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others.